Search


Current filters:


Start a new search
Add filters:

Use filters to refine the search results.


Results 1-10 of 40 (Search time: 0.003 seconds).
Item hits:
PreviewIssue DateTitleAuthor(s)
2012Identifying and quantifying prognostic factors in SSc-related interstitial lung disease using a time-varying covariate survival modelMoore, O.; Goh, N.; Corte, T.; Rouse, H.; Hennessy, O.; Byron, J.; Thakkar, V.; Sahhar, J.; Roddy, J.; Youssef, P.; Nash, P.; Zochling, J.; Proudman, S.; Stevens, W.; Nikpour, M.; 2nd Systemic Sclerosis World Congress (02 Feb 2012 - 04 Feb 2012 : Madrid, Spain)
2013Extent of disease on high-resolution computed tomography lung is a predictor of decline and mortality in systemic sclerosis-related interstitial lung diseaseMoore, O.; Goh, N.; Corte, T.; Rouse, H.; Hennessy, O.; Thakkar, V.; Byron, J.; Sahhar, J.; Roddy, J.; Gabbay, E.; Youssef, P.; Nash, P.; Zochling, J.; Proudman, S.; Stevens, W.; Nikpour, M.
2016The association of low complement with disease activity in systemic sclerosis: a prospective cohort studyEsposito, J.; Brown, Z.; Stevens, W.; Sahhar, J.; Rabusa, C.; Zochling, J.; Roddy, J.; Walker, J.; Proudman, S.; Nikpour, M.
2012N-terminal pro-brain natriuretic peptide in a novel screening algorithm for pulmonary arterial hypertension in systemic sclerosis: a case-control studyThakkar, V.; Stevens, W.; Prior, D.; Moore, O.; Byron, J.; Liew, D.; Patterson, K.; Hissaria, P.; Roddy, J.; Zochling, J.; Sahhar, J.; Nash, P.; Tymms, K.; Celermajer, D.; Gabbay, E.; Youssef, P.; Proudman, S.; Nikpour, M.
2015Quantifying change in pulmonary function as a prognostic marker in systemic sclerosis-related interstitial lung diseaseMoore, O.; Proudman, S.; Goh, N.; Corte, T.; Rouse, H.; Hennessy, O.; Morrisroe, K.; Thakkar, V.; Sahhar, J.; Roddy, J.; Youssef, P.; Gabbay, E.; Nash, P.; Zochling, J.; Stevens, W.; Nikpour, M.
2014Mycophenolate mofetil versus azathioprine in scleroderma-associated interstitial lung disease: results from the Australian Scleroderma Cohort StudyOwen, C.; Ngian, G.; Moore, O.; Stevens, W.; Proudman, S.; Roddy, J.; Zochling, J.; Nash, P.; Hill, C.; Sturgess, A.; Sahhar, J.; Australian Rheumatology Association 55th Annual Scientific Meeting (17 May 2014 - 20 May 2014 : Hobart, Tasmania)
2016Mycophenolate mofetil is an effective and safe option for the management of systemic sclerosis-associated interstitial lung disease: results from the Australian Scleroderma Cohort studyOwen, C.; Ngian, G.; Elford, K.; Moore, O.; Stevens, W.; Nikpour, M.; Rabusa, C.; Proudman, S.; Roddy, J.; Zochling, J.; Hill, C.; Sturgess, A.; Tymms, K.; Youssef, P.; Sahhar, J.
2014The association of antiphospholipid antibodies with cardiopulmonary manifestations of systemic sclerosisMorrisroe, K.; Stevens, W.; Nandurkar, H.; Prior, D.; Thakkar, V.; Roddy, J.; Zochling, J.; Sahhar, J.; Tymms, K.; Sturgess, A.; Major, G.; Kermeen, F.; Hill, C.; Walker, J.; Nash, P.; Gabbay, E.; Youssef, P.; Proudman, S.; Nikpour, M.
2012An immunochip-based interrogation of scleroderma susceptibility variantsCharlesworth, J.; Stankovich, J.; Lewis, P.; Byron, J.; Stevens, W.; Sahhar, J.; Proudman, S.; Roddy, J.; Nash, P.; Tymms, K.; Brown, M.; Zochling, J.; 2nd Systemic Sclerosis World Congress (02 Feb 2012 - 04 Feb 2012 : Madrid, Spain)
2017Validity of the Workers Productivity and Activity Impairment Questionnaire: Specific Health Problem (WPAI:SHP) in patients with systemic sclerosisMorrisroe, K.; Stevens, W.; Huq, M.; Sahhar, J.; Ngian, G.; Zochling, J.; Roddy, J.; Proudman, S.; Nikpour, M.; Rischmueller, M.; ustralian Scleroderma Interest Group (ASIG)